Immunomedics Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (29)

Latest Posts

About This Stock More About This Stock
Oracle Wins TikTok Bid, Nvidia Buys Arm For $40bn
Article By: Adam Vettese
Monday, September 14, 2020 6:00 AM EDT
The weekend was packed with M&A news, with three deals all likely to be well north of $10bn apiece reported. First up, Oracle has reportedly won the bidding to buy TikTok’s US operations, with the Microsoft-Walmart joint offer being rejected.
In this article: APA, CVX, IAG, LEN, OXY, WMT, XOM, AIVAF, GLCNF, IMMU, AAPL, ARMH, GILD, INTC, MSFT, NVDA, ORCL, DIA, FXB, SPY, COMP, SPX, BITCOMP, NGLOY, ETH-X, JDDSF, RTPPF, SFTBY
Read
Gilead To Explore Trodelvy Drug Against Different Cancers After $21B Merger With Immunomedics
Article By: Benzinga
Monday, September 14, 2020 4:50 AM EDT
After initial reports emerged on Saturday about a potential acquisition deal, Gilead Sciences Inc. confirmed that it's set to purchase Immunomedics Inc. 
In this article: IMMU, GILD
Read
Gilead Sciences To Acquire Immunomedics
Article By: Business Wire
Sunday, September 13, 2020 3:51 PM EDT
Gilead Sciences, Inc. and Immunomedics announced that the companies have entered into a definitive agreement pursuant to which Gilead will acquire Immunomedics for $88.00 per share. The transaction values Immunomedics at approximately $21 billion.
In this article: IMMU, GILD Also: KITE
Read
Gilead Sciences And Cancer Treatment Company Immunomedics In $20B Deal
Article By: Benzinga
Sunday, September 13, 2020 5:49 AM EDT
Gilead Sciences Inc. is gearing up to purchase drug innovator Immunomedics Inc. for a price tag exceeding $20 billion.
In this article: IMMU, GILD
Read
Immunomedics Price Target Raised To $55 From $41 At Wells Fargo
Article By: The Fly
Monday, July 6, 2020 10:52 AM EDT
Wells Fargo analyst Jim Birchenough raised the firm's price target on Immunomedics to $55 from $41.
In this article: IMMU
Read

PARTNER HEADLINES

Latest Tweets for $IMMU

No tweets yet!